Reuters logo
BRIEF-Paratek Pharma antibiotic granted additional qualified infectious disease product designation by FDA​
2017年9月21日 / 中午12点14分 / 1 个月前

BRIEF-Paratek Pharma antibiotic granted additional qualified infectious disease product designation by FDA​

Sept 21 (Reuters) - Paratek Pharmaceuticals Inc

* Paratek Pharmaceuticals Inc - its antibiotic omadacycline has been granted additional qualified infectious disease product designation by U.S. FDA​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below